The Mosquito Borne Diseases Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Mosquito Borne Diseases Market?
The global market for mosquito borne diseases has seen significant growth in the past few years. It is expected to increase from a value of $3.06 billion in 2024 to $3.31 billion in 2025, projecting a compound annual growth rate (CAGR) of 8.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Mosquito Borne Diseases Industry?
The Mosquito Borne Diseases Global Market is expected to grow to $4.51 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%.
Download Your Free Sample of the 2025 Mosquito Borne Diseases Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Mosquito Borne Diseases Market?
The key drivers in the mosquito borne diseases market are:
•Rising investments in vector control programs
•Increasing focus on healthcare infrastructure
•Growth in travel and tourism to mosquito-borne disease endemic regions
•Emergence of drug-resistant mosquito strains and government initiatives for disease eradication
Global Market Segmentation: Identifying Major Mosquito Borne Diseases Industry Segments
The mosquito borne diseases market covered in this report is segmented –
1) By Disease Type: Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus, Other Disease Types
2) By Treatment Type: Medication, Vaccination, Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types
3) By End User: Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, Non-Governmental Organizations, Other End Users
Subsegments:
1) By Malaria: Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types
2) By Dengue: Dengue Fever, Severe Dengue (Dengue Hemorrhagic Fever)
3) By Yellow Fever: Acute Yellow Fever, Chronic Yellow Fever
4) By West Nile Virus: Neuroinvasive Disease (Encephalitis, Meningitis), Non-neuroinvasive Disease
5) By Chikungunya: Acute Chikungunya, Chronic Chikungunya
6) By Zika Virus: Acute Zika Infection, Congenital Zika Syndrome
7) By Other Disease Types: Japanese Encephalitis, La Crosse Encephalitis, Eastern Equine Encephalitis (EEE), Other Mosquito-Borne Infections
Pre-order the 2025 Mosquito Borne Diseases Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Mosquito Borne Diseases Market?
The key trends in the mosquito borne diseases market are:
•Development of insecticide-treated bed nets is a notable emerging trend.
•Introduction of rapid diagnostic test kits are shaping the future market.
•Advancements in vector control techniques are increasingly influential.
•The market is significantly influenced by the development of advanced diagnostic tools.
Who Are the Top Competitors & Leading Players in the Mosquito Borne Diseases Market?
Major players in the mosquito borne diseases market are:
• Johnson & Johnson
• Merck & Co. Inc.
• Sanofi S.A.
• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• Syngenta
• Takeda Pharmaceuticals
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Serum Institute of India Pvt. Ltd.
• Orkin Inc.
• RTI International
• Emergent BioSolutions
• Valneva SE
• BioCryst Pharmaceuticals Inc.
• Bharat Biotech
• Vector Control International
• Clarke Environmental Mosquito Management
• Inovio Pharmaceuticals
• Oxitec Ltd.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the mosquito borne diseases market in 2024
